"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...
Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.
The analysis conducted by doctors showed that 376 million people are carriers of the herpes virus HSV-1, and 519 million are ...
Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...
Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...
A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...
The New York State Department of Health AIDS Institute wrapped up its Ending the Epidemic Summit and World AIDS Day events at the Albany Capital Center.
A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the ...
Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...
Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir significantly more ...
A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...
A qualitative study spoke to emergency department and HIV clinic staff to evaluate the feasibility of initiating pre-exposure ...